A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder.
Clinical trial NCT05279313 · COMPLETED
Trial details
- NCT number
- NCT05279313
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2026-04-24
- Enrollment
- 680
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.